![Study protocol: Minimum effective low dose: anti-human thymocyte globulin (MELD-ATG): phase II, dose ranging, efficacy study of antithymocyte globulin (ATG) within 6 weeks of diagnosis of type 1 diabetes | BMJ Open Study protocol: Minimum effective low dose: anti-human thymocyte globulin (MELD-ATG): phase II, dose ranging, efficacy study of antithymocyte globulin (ATG) within 6 weeks of diagnosis of type 1 diabetes | BMJ Open](https://bmjopen.bmj.com/content/bmjopen/11/12/e053669/F1.large.jpg)
Study protocol: Minimum effective low dose: anti-human thymocyte globulin (MELD-ATG): phase II, dose ranging, efficacy study of antithymocyte globulin (ATG) within 6 weeks of diagnosis of type 1 diabetes | BMJ Open
In vivo effects of horse and rabbit antithymocyte globulin in patients with severe aplastic anemia | Haematologica
Presumed Serum Sickness Following Thymoglobulin Treatment of Acute Cellular Rejection of a Cardiac Allograft | MDedge Dermatology
![Presumed Serum Sickness Following Thymoglobulin Treatment of Acute Cellular Rejection of a Cardiac Allograft | MDedge Dermatology Presumed Serum Sickness Following Thymoglobulin Treatment of Acute Cellular Rejection of a Cardiac Allograft | MDedge Dermatology](https://cdn.mdedge.com/files/s3fs-public/Image/September-2017/ct100003186_fig.png)
Presumed Serum Sickness Following Thymoglobulin Treatment of Acute Cellular Rejection of a Cardiac Allograft | MDedge Dermatology
![Complications of autologous hematopoietic stem cell transplantation for patients with autoimmune diseases | Pediatric Research Complications of autologous hematopoietic stem cell transplantation for patients with autoimmune diseases | Pediatric Research](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fpr.2011.57/MediaObjects/41390_2012_Article_BFpr201157_Fig1_HTML.gif)
Complications of autologous hematopoietic stem cell transplantation for patients with autoimmune diseases | Pediatric Research
![Rabbit antithymocyte globulin-induced serum sickness disease and human kidney graft survival. - Abstract - Europe PMC Rabbit antithymocyte globulin-induced serum sickness disease and human kidney graft survival. - Abstract - Europe PMC](https://europepmc.org/articles/PMC4665787/bin/JCI82267.f1.jpg)
Rabbit antithymocyte globulin-induced serum sickness disease and human kidney graft survival. - Abstract - Europe PMC
![Serum Sickness Jill Tichy, M.D. PGY III. Serum Sickness What is it? Immunization of host (human) by heterologous (non-human) serum proteins caused by. - ppt download Serum Sickness Jill Tichy, M.D. PGY III. Serum Sickness What is it? Immunization of host (human) by heterologous (non-human) serum proteins caused by. - ppt download](https://images.slideplayer.com/16/5143116/slides/slide_2.jpg)